TITLE

Review: Metformin used alone or combined with clomifene may improve ovulation rates in the polycystic ovary syndrome: COMMENTARY

AUTHOR(S)
Hoeger, Kathleen M.; Guzick, David S.
PUB. DATE
May 2004
SOURCE
ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p75
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Polycystic ovary syndrome (PCOS) is characterized by oligo-ovulation, irregular menses, and symptoms of androgen excess, such as hirsutism and acne. It is a common endocrinopathy affecting 5% to 10% of women of reproductive age. Insulin resistance is felt to play a key role in most women with PCOS, therefore insulin-sensitizing agents have moved to the forefront of management of PCOS. No large-scale, long-term studies of their use in PCOS have been reported thus far. This study combines the results of 15 randomized clinical trials (RCT) using insulin-sensitizing agents in the treatment of PCOS. The primary outcome measure in 11 of the 15 RCTs was ovulation. Because data are mainly available for metformin use, the conclusions are essentially restricted to this drug.
ACCESSION #
13221852

 

Related Articles

  • Responsive to Thiazolidinediones but not Metformin.  // Fertility Weekly;2/16/2009, p7 

    The article discusses the usefulness of insulin sensitivity and adipose tissue topography to determine proper treatment for patients with polycystic ovary syndrome (PCOS). It is found that PCOS is a common endocrine disorder that affects nearly seven percent of reproductive aged women....

  • When should we use metformin in PCOS? Franks, Stephen // Pulse;11/3/2003, Vol. 63 Issue 44, p96 

    Determines which women with polycystic ovary syndrome (PCOS) should receive metformin. Lack of randomized controlled trials to assess efficacy of metformin; Support for the notion that metformin improves the frequency of ovulation.

  • Evaluation of Ovarian Cysts. HOLZER, ROBIN A.; PERSONS, ROBERT K.; JAMIESON, BARBARA // American Family Physician;8/1/2011, Vol. 84 Issue 3, p3 

    The article provides an answer to a question of what type of follow-up should a physician conduct for a patient with an ovarian cyst identified on ultrasonography.

  • The Use of Kigelia africana in the Management of Polycystic Ovary Syndrome (PCOS). Oyelami, Oyeku A.; Yusuf, Kafayat O.; Oyelami, Atinuke O. // Chinese Medicine (2151-1918);Mar2012, Vol. 3 Issue 1, p1 

    This paper reports the beneficial effect of twice daily ingestion (a table spoonful) of dried Kigelia africana fruit powder in the management of Polycystic Ovary Syndrome (PCOS) in two patients. Both patients had the classical triad of Amenorrhoea, acne and hirsutism. The two were 25 years old...

  • In Vitro Maturation vs. In Vitro Fertilization.  // Fertility Weekly;10/1/2012, p2 

    The article compares the use of in vitro maturation (IVM) and vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) for treating women with polycystic ovaries (PCO). It is mentioned that IVF can lead to higher chances of ovarian hyperstimulation syndrome (OHSS), which can prove fatal...

  • Multicystic ovarian disease secondary to hypothyroidism in a prepubertal girl. Gupta, S. P.; Mittal, Amit; Mehta, Vinod; Mahendru, Rajeev // Annals of Tropical Medicine & Public Health;Jul-Dec2011, Vol. 4 Issue 2, p107 

    We present a case of bilateral ovarian enlargement with multiple ovarian cysts associated with hypothyroidism in a prepubescent female. The patient was managed conservatively with hormonal therapy.

  • Relationship between ultrasound parameters and intra cytoplasmic sperm injection outcome in polycystic ovarian syndrome treated by non agonist step up stimulation protocol. Orief, Yasser Ibrahim; El-agwany, Ahmed Samy; Elmoneem Darwish, Emad Abd; Abdel Rahman, Ashraf Hany; Ghazal, Sherin Mahmoud // Middle East Fertility Society Journal;Jun2015, Vol. 20 Issue 2, p103 

    Objective: To correlate the ultrasound parameters to the intra-cytoplasmic sperm injection outcome in polycystic ovarian syndrome cases treated by non-agonist chronic step up stimulation protocol. Setting: Agial and Integrated Fertility Centers, Alexandria, Egypt. Patients: Twenty-five cases of...

  • The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin. Cakiroglu, Y.; Vural, B.; Isgoren, S. // Archives of Gynecology & Obstetrics;Jul2013, Vol. 288 Issue 1, p213 

    Purpose: Polycystic ovary syndrome (PCOS) is considered as the most common endocrinopathy among women of reproductive age. Oral contraceptives (OCs) and metformin are one of the main drug groups in the long-term treatment of PCOS. This study was undertaken to investigate the effects of...

  • Therapeutic Effects of Biguanide Vs. Statin in Polycystic Ovary Syndrome: A Randomized Clinical Trial. Navali, Nazli; Pourabolghasem, Shabnam; Fouladi, Rohollah Fadaei; Nikpour, Mehri Amiri // Pakistan Journal of Biological Sciences;6/1/2011, Vol. 14 Issue 11, p658 

    Various classes of medication are currently being used in Polycystic Ovary Syndrome (PCOS) patients including the biguanides and the statins. However, their efficacies are rarely compared. This study aimed to compare efficacy of a biguanide and a statin in treating PCOS. In a randomized...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics